Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn't help outcomes for complex patients not in cardiogenic shock, two randomized ...

Freeman Heart & Vascular Institute has earned Level 1 STEMI designation from the Missouri Department of Health and Senior ...

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary ...

In the STEMI Door-to-Unload trial, use of Impella missed the mark in patients with anterior MI without cardiogenic shock.

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage.

This screenshot from an Abiomed video demonstrates placement of the Impella 2.5 and Impella CP. Delivered in a minimally invasive way, Impella pumps actively unload the heart, aiding native heart ...

A combination of left ventricular support plus delayed percutaneous coronary intervention did not reduce infarct size compared with immediate PCI in patients with anterior STEMI without shock, ...

myocardial infarction, heart attack Even patients with advanced CKD or receiving dialysis appear to benefit from guideline-directed STEMI therapies, according to a retrospective study. Patients with ...

PARIS, France—In patients with STEMI and multivessel disease, quantitative flow ratio (QFR) may provide better information than fractional flow reserve (FFR) on how nonculprit lesions will affect ...

When reading the ECG of a patient presenting with cardiopulmonary complaints, the most important duty of acute care clinicians is to determine whether there is evidence of an acute coronary occlusion ...